Faron Pharmaceuticals Oy (LON:FARN) Stock Price Passes Below 50-Day Moving Average of $257.53

Faron Pharmaceuticals Oy (LON:FARNGet Free Report)’s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 257.53 ($3.27) and traded as low as GBX 145 ($1.84). Faron Pharmaceuticals Oy shares last traded at GBX 147.50 ($1.87), with a volume of 88,818 shares traded.

Faron Pharmaceuticals Oy Stock Down 4.3 %

The company has a debt-to-equity ratio of 121.51, a current ratio of 1.08 and a quick ratio of 1.09. The company has a market capitalization of £97.16 million, a PE ratio of -351.19 and a beta of -0.10. The business’s 50 day simple moving average is GBX 257.53 and its 200 day simple moving average is GBX 284.07.

Faron Pharmaceuticals Oy Company Profile

(Get Free Report)

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies.

Further Reading

Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.